Catalyst Event
Medpace Holdings Inc (MEDP) · Earnings Release
From KEDI Global Longevity Bio Index (KGLB)
4/20/2026, 12:00:00 AM
Q1 2026 earnings release is scheduled. Analysts forecast EPS of approximately $3.90 - $4.01 and revenue around $697.82M. Medium importance is estimated based on historical earnings volatility exceeding 5% scheduled.
Korean Translation
분석가들이 주당순이익(EPS) 약 3.90~4.01달러, 매출 약 6억 9,782만 달러로 전망하며 과거 변동성을 고려해 중요도를 'Medium'으로 예상하는 2026년 1분기 실적 발표가 예정됨.
Related Recent Events
Ionis Pharmaceuticals Inc (IONS) · Other
FDA target action (PDUFA) date for olezarsen for the treatment of severe hypertriglyceridemia (sHTG) following acceptance of sNDA for Priority Review. This is a major potential approval for a broad patient population, scheduled.
6/30/2026, 12:00:00 AM
Biogen Inc (BIIB) · Earnings Release
Q1 2026 earnings release (Low impact estimated as routine earnings releases typically see at least 1% volatility) scheduled.
5/6/2026, 12:00:00 AM
Bristol-Myers Squibb Co (BMY) · Earnings Release
Bristol-Myers Squibb is scheduled to announce its first-quarter 2026 financial results on April 30, 2026, scheduled.
4/30/2026, 12:00:00 AM
Eli Lilly and Co (LLY) · Earnings Release
Q1 2026 earnings release scheduled; a price impact of at least 1% is expected.
4/30/2026, 12:00:00 AM
Teva Pharmaceutical Industries Ltd (TEVA) · Earnings Release
Teva is scheduled to release its first quarter 2026 financial results and host a conference call on April 29, 2026; importance is estimated at Medium as earnings reports typically drive significant price volatility, expected.
4/29/2026, 12:00:00 AM
Sanofi (SNY) · Earnings Release
First quarter 2026 earnings results are scheduled to be released on April 23, 2026. This is expected to have a low impact as a routine financial update, scheduled.
4/23/2026, 12:00:00 AM